Monday, October 30, 2017 7:09:05 PM
2. buck institute begs to differ. demonstratively helpful to stem cell therapies
3.Fumi Urano begs to differ. Human trial by 2020
4.Funding is dire and critical
5. Maybe he will. He's staying on the field
6. AMBS is owned by its shareholders. Not CHF. Spreading FUD and nonsense
7. I'm hip old man, don't you worry
MANF is a protein in a box
nothing more - nothing less
it is being surpassed by stem cell advances left and right
it is at least 5 - 7 years away from any conceivable human trials whatsoever
and of course, funding appears to be the most dire and critical need - as usual
who knows, maybe Gerald will sell his $130k Tesla and throw those coins in the MANF development bucket
instead of continually sucking AMBS dry
and royally screwing his few remaining loyal shareholders
with lavish travel, high fluting dining, and an unlimited expense account
Oh wiat - that's right
Gerald sold AMBS for $25k to Chang of SeD
so he could now fleece AVDX shareholders
get hip - or get swindled...Brah
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM